secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARDELYX, INC. (ARDX)
CIK:        0001437402
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001628280-24-006321
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ardelyx reports FY2023 revenue $124.5M; IBSRELA sales $80.1M, guides 2024 $140-150M
--------------------------------------------------------------------------------

- IBSRELA net product sales $80.1M in FY2023, Q4 $28.1M (+26% QoQ); guides 2024 sales $140-150M.
- XPHOZAH launch nets $2.5M in Q4 2023; initiated real-world study.
- Total revenue $124.5M in 2023 (up 138% YoY from $52.2M); net loss $66.1M ($0.30 per share).
- Cash and investments $184.3M at year-end, up from $123.9M; drew $22.4M from SLR term loan.
- Kyowa Kirin launched PHOZEVEL (tenapanor) in Japan Feb 20, 2024; Ardelyx received $3M milestone from Fosun.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1437402/000162828024006321/0001628280-24-006321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1437402/000162828024006321/ardx-20240222.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-006321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer